Literature DB >> 2315918

Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.

J W Fisher1, T A Whittaker, D H Taylor, H J Clewell, M E Andersen.   

Abstract

A physiologically based pharmacokinetic (PB-PK) model was developed to describe trichloroethylene (TCE) kinetics in the lactating rat and nursing pup. The lactating dam was exposed to TCE either by inhalation or by ingestion in drinking water. The nursing pup's exposure to TCE was by ingestion of maternal milk containing TCE. The kinetics of trichloroacetic acid (TCA), a metabolite of TCE, were described in the lactating dam and developing pup by a hybrid one-compartment model. The lactating dam's exposure to TCA was from metabolism of TCE to TCA. The pup's exposure to TCA was from metabolism of TCE ingested in suckled milk and from direct ingestion of TCA in maternal milk. For the PB-PK model, partition coefficients (PCs) were determined by vial equilibration, and metabolic constants for TCE oxidation, by gas uptake methods. The blood/air and the fat/blood PCs for the dam were 13.1 and 34.2, and for the pup, 10.6 and 42.3, respectively. The milk/blood PC for the dam was 7.1. In lactating rats and rat pups (19-21 days old) the maximum velocities of oxidative metabolism were 9.26 +/- 0.073 and 12.94 +/- 0.107 mg/kg/hr. The plasma elimination rate constant (K = 0.063 +/- 0.004 hr-1) and apparent volume of distribution (Vd = 0.568 liter/kg) for TCA in the lactating dam were estimated from both intravenous dosing studies and an inhalation study with TCE. For the pup, K (0.014 +/- hr-1) and Vd (0.511 liter/kg) were estimated from a single 4-hr inhalation exposure with TCE. The dose-rate-dependent stoichiometric yield of TCA from oxidative metabolism of TCE in the lactating rat is 0.17 for a low-concentration inhalation exposure (27 ppm TCE) and 0.27 for an exposure above metabolic saturation (about 600 ppm TCE). For the pup, the stoichiometric yield of TCA is 0.12. With changing physiological values during lactation for compartmental volumes, blood flows, and milk yields obtained from the published literature and kinetic parameters and PCs determined by experimentation, a PB-PK model was constructed to predict maternal and pup concentrations of TCE and TCA. To test the fidelity of the PB-PK lactation model, a multiday inhalation exposure study was conducted from Days 3 to 14 of lactation and a drinking water study, from Days 3 to 21 of lactation. The inhalation exposure was 4 hr/day, 5 days/week, at 610 ppm. The TCE concentration in the drinking water was 333 micrograms/ml. Prediction compared favorably with limited data obtained at restricted time points during the period of lactation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315918     DOI: 10.1016/0041-008x(90)90045-v

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk.

Authors:  Geniece M Lehmann; Marc-André Verner; Bryan Luukinen; Cara Henning; Sue Anne Assimon; Judy S LaKind; Eva D McLanahan; Linda J Phillips; Matthew H Davis; Christina M Powers; Erin P Hines; Sami Haddad; Matthew P Longnecker; Michael T Poulsen; David G Farrer; Satori A Marchitti; Yu-Mei Tan; Jeffrey C Swartout; Sharon K Sagiv; Clement Welsh; Jerry L Campbell; Warren G Foster; Raymond S H Yang; Suzanne E Fenton; Rogelio Tornero-Velez; Bettina M Francis; John B Barnett; Hisham A El-Masri; Jane Ellen Simmons
Journal:  Crit Rev Toxicol       Date:  2014-08       Impact factor: 5.635

3.  Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. II. 1,1,1-Trichloroethane and trichloroethylene.

Authors:  S Laparé; R Tardif; J Brodeur
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

Review 4.  Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.

Authors:  D Krewski; J R Withey; L F Ku; M E Andersen
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

Review 5.  Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.

Authors:  J W Fisher
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 6.  Human variability and susceptibility to trichloroethylene.

Authors:  G M Pastino; W Y Yap; M Carroquino
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 7.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 8.  Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario.

Authors:  W K Boyes; P J Bushnell; K M Crofton; M Evans; J E Simmons
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

9.  A Physiologically-Based Pharmacokinetic Model for Targeting Calcitriol-Conjugated Quantum Dots to Inflammatory Breast Cancer Cells.

Authors:  James Forder; Mallory Smith; Margot Wagner; Rachel J Schaefer; Jonathon Gorky; Kenneth L van Golen; Anja Nohe; Prasad Dhurjati
Journal:  Clin Transl Sci       Date:  2019-07-15       Impact factor: 4.689

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.